^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    ROR1-targeted CAR-T immunotherapy

    Related drugs:
    Apply
    A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451)
    Phase 1
    Lyell Immunopharma, Inc.
    Recruiting
    Last update posted :
    03/01/2024
    Initiation :
    03/29/2022
    Primary completion :
    03/01/2025
    Completion :
    09/01/2026
    ROR1
    |
    LYL797
    A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies (NCT05588440)
    Phase 1/2
    Oncternal Therapeutics, Inc
    Recruiting
    Last update posted :
    11/30/2023
    Initiation :
    05/09/2023
    Primary completion :
    12/01/2026
    Completion :
    12/01/2037
    CCND1
    |
    CCND1 overexpression
    |
    cyclophosphamide • ONCT-808
    A Study of RD14-01 in Patients With Advanced Solid Tumors (NCT05748938)
    Phase 1/2
    920th Hospital of Joint Logistics Support Force...
    Recruiting
    Last update posted :
    03/01/2023
    Initiation :
    02/08/2023
    Primary completion :
    08/08/2024
    Completion :
    02/08/2025
    ROR1
    |
    RD14-01
    A Study of RD14-01 in Patients With Advanced Solid Tumors (NCT05638828)
    Phase 1
    Shen Lin
    Not yet recruiting
    Last update posted :
    12/06/2022
    Initiation :
    12/01/2022
    Primary completion :
    12/01/2023
    Completion :
    12/01/2024
    ROR1
    |
    RD14-01